Log In
BCIQ
Print this Print this
 

BI 661051

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation
PartnerEvotec AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today